| 000 | 01794 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514232039.0 | ||
| 264 | 0 | _c20051003 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a0022-3573 | ||
| 024 | 7 |
_a10.1211/0022357056064 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBadenhorst, H E | |
| 245 | 0 | 0 |
_aHistamine-3 receptor antagonists reduce superoxide anion generation and lipid peroxidation in rat brain homogenates. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacy and pharmacology _cJun 2005 |
||
| 300 |
_a781-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aAspirin _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHistamine Agonists _xpharmacology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Cyanide _xadverse effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Histamine H3 _xdrug effects |
| 650 | 0 | 4 |
_aSuperoxides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThiourea _xanalogs & derivatives |
| 700 | 1 | _aMaharaj, D S | |
| 700 | 1 | _aMalan, S F | |
| 700 | 1 | _aDaya, S | |
| 700 | 1 | _avan Dyk, S | |
| 773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 57 _gno. 6 _gp. 781-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1211/0022357056064 _zAvailable from publisher's website |
| 999 |
_c15628218 _d15628218 |
||